C
Citius Oncology, Inc. (CTOR)
NCM – Real vaqt narxi. Valyuta: USD
0.75
+0.02 (2.74%)
Bozor ochiq: Aug 12, 2026, 11:59 AM EDT
0.73
0.00 (0.00%)
Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
0.75
+0.02 (2.74%)
Bozor ochiq: Aug 12, 2026, 11:59 AM EDT
0.73
0.00 (0.00%)
Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT
Citius Oncology, Inc. maqsadli onkologik terapiyalarni ishlab chiqish va tijoratlashtirishga qaratilgan. Kompaniya, shuningdek, notekis bo'lmagan limfoma turi bo'lgan teri T-hujayrali limfomasining qaytalangan yoki refrakter kattalar bemorlarini davolash uchun mo'ljallangan LYMPHIRni ishlab chiqish bilan shug'ullanadi. Kompaniya shtab-kvartirasi Cranford, New Jerseyda joylashgan. Citius Oncology, Inc. Leonard-Meron Biosciences, Inc. sho'ba korxonasi sifatida faoliyat yuritadi.
| Ism | Lavozim |
|---|---|
| Dr. Myron S. Czuczman M.D. | Executive VP & Chief Medical Officer |
| Mr. Jaime Bartushak | Chief Financial Officer & Treasurer |
| Mr. Leonard L. Mazur | CEO, President & Executive Chairman |
| Mr. Myron Z. Holubiak | Secretary & Executive Vice Chairman |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-08-05 | 8-K | ea0300371-8k_citius.htm |
| 2026-06-01 | 8-K | ea0292903-8k_citius.htm |
| 2026-05-29 | S-3 | ea0291447-s3_citius.htm |
| 2026-05-29 | DEF 14C | ea0292248-def14c_citius.htm |
| 2026-05-19 | PRE 14C | ea0290807-pre14c_citius.htm |
| 2026-05-15 | 8-K | ea0291035-8k_citius.htm |
| 2026-05-15 | 10-Q | ea0290553-10q_citius.htm |
| 2026-05-06 | 8-K | ea0289297-8k_citius.htm |
| 2026-04-29 | 8-K | ea0288202-8k_citius.htm |
| 2026-04-28 | 8-K | ea0288020-8k_citius.htm |